戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 medication for nicotine dependence and other substance-related disorders.
2 d Hispanics (21.0%) had the highest rates of substance-related disorders.
3 ined treatment for other comorbid mental and substance-related disorders.
4 fic negative course marked by antisocial and substance-related disorders.
5 sorders to the chapter formerly reserved for substance-related disorders.
6 oups also are disproportionately affected by substance-related disorders.
7  population in the United States, data about substance-related disorders among adolescents of various
8 t substance users indicated elevated odds of substance-related disorders among Native Americans, adol
9 f 642 patients were assessed, of whom 39 had substance-related disorder and dysthymia and 308 had sub
10                                Patients with substance-related disorder and dysthymia are referred to
11                                Patients with substance-related disorder and dysthymia had received mo
12                                Patients with substance-related disorder and dysthymia used 4.7 times
13 vious treatment among patients with comorbid substance-related disorder and dysthymia, as compared to
14 s several times higher for the patients with substance-related disorder and dysthymia.
15 ncreased co-occurring anxiety-, stress-, and substance-related disorders, and they used this informat
16 e-related disorder and dysthymia and 308 had substance-related disorder only (the remaining patients
17 rder treatment more often than patients with substance-related disorder only but are referred to (or
18 isorder treatment dollars than patients with substance-related disorder only, although their demograp
19 c treatment no more often than patients with substance-related disorder only.
20  and dysthymia, as compared to patients with substance-related disorder only.
21 dentified several highly comorbid disorders (substance-related disorders, personality disorders, depr
22 ofit: 18.8%, proprietary: 12.6%), a comorbid substance-related disorder (public: 29.9%, nonprofit: 31
23                                     Although substance-related disorder treatment differed considerab
24 d disorder and dysthymia used 4.7 times more substance-related disorder treatment dollars than patien
25 ted disorder and dysthymia had received more substance-related disorder treatment in 18 of 20 measure
26 rder and dysthymia are referred to (or seek) substance-related disorder treatment more often than pat
27                         The cost of previous substance-related disorder treatment was several times h
28                                              Substance-related disorders were assessed by standardize
29 e more likely in psychosis spectrum 22q11DS; substance-related disorders were more likely in ND.
30 gs in the past year; 7.9% met criteria for a substance-related disorder, with Native Americans having
31                                    The DSM-5 Substance-Related Disorders Work Group considered these

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。